Market_Media_Hub

 The global data analysis, storage & management market in life sciences is expected to register a CAGR of 12.0% during the forecast period and is expected to hit USD 43,895.69 million.  Data analysis, storage, and management  provides operational benefits to an organization by enhancing the efficiency of electronic data storage. The data analysis, storage & management market in life sciences is growing due to the increasing government initiatives to increase the adoption of different  data-based solutions  and the growing demand for data storage and management solutions due to the extensive amount of data generated in the life science field. Additionally, the increasing growth strategies adopted by major players are also driving the market growth. MRFR recognizes the following as the key players in the global  data analysis, storage & management market in life sciences companies  — Hewlett Packard Enterprise (US), Dell Technologies Inc. (US), Advanced Micro Devices, Inc. (U

 Global Automated Cell Culture Market is expected to register a CAGR of 8.18% during the forecast period and expected to hit USD 16,287.9 Million by end of forecast period. The automation in the steps involved in cell culture has several advantages, such as reducing time and saving labor costs. Automation ensures consistency of the procedure and provides sterility that even the best technicians cannot attain. Automated cell culture  is a process in which the growth and maintenance of cell culture are taken with advanced techniques. Cell culture is a process of removing the cells from the source to grow under the specified technical environment outward of the natural environment. Automated cell culture performs the steps involved in growing and maintaining the cell culture system. Traditionally, cell culture has been a manual process that requires many hours of repetitive, painstaking work to maintain absolute sterility. Automated cell culture systems  are easy to operate and capable of

 ePharmacy is an online service that aids consumers to order medicines online and delivers them to the doorstep. Such an order can be placed through e-commerce platforms, shipping companies, or via mail. Increasing penetration of the internet, e-commerce, and a proliferated adoption of smartphones have enabled the healthcare sector to deploy technologically advanced solutions such as ePharmacy Market was valued at USD 62,587.0 Million   and is expected to register a CAGR of 12.5% during the forecast period .  The most crucial market driving factors for the global ePharmacy market growth are increasing penetration of the internet and the proliferation of smartphone users. The modern gadgets and the internet facilitate the healthcare sector to deploy technologically advanced healthcare solutions including ePharmacy. Ease of use is another important market driving factor as it is easy for patients to order medicine online. High demand for online availability of medicines and medical devic

 The global patient handling equipment market is predicted to develop due to an increase in the use of patient handling equipment in hospitals, rehabilitation facilities, and aged care settings. The expanding elderly population and the growing patient population of chronic diseases are the two primary market influencers in the patient handling equipment market. Due to the fast expansion of chronic diseases, the number of disabled persons is increasing. To carry out their everyday activities, disabled persons require patient handling equipment. Increasing occurrences of disability will drive the  market for patient handling equipment  to rise significantly throughout the forecast period. Furthermore, the COVID-19 outbreak has resulted in a significant increase in the demand for medical beds all over the world. A growing number of individuals are being admitted to hospitals as a result of the COVID-19 pandemic. As the number of corona cases rises around the world, governments in both dev

Market Research Future (MRFR) confirms that the Neurodiagnostics market 2020 can procure a growth rate of 6.88% over the appraisal period. We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak. Although SARS-CoV-2 does not cause any  neurological disease , it can still lead to CNS/central nervous system infection, along with para-infectious issues. More than a million novel coronavirus cases have been reported across the world, despite the lockdown imposed. However, definitive proof is insufficient to say that neurological disorders are associated with the pandemic. Currently, the healthcare is primarily focused on dealing with the COVID-19 outbreak, and the focus on Neurodiagnostics has gone down to some extent. With that said, the surging life expectancy and the consequent expansion of the elderly population can be favorable for the  Neurodiagnostics market . Since the geriatric popu

 The growth of the critical illness insurance market is expected to be fueled by rising critical illness cases and rising out-of-pocket expenses for both insured and uninsured people. Every illness, disorder, or health condition that is life-threatening and necessitates comprehensive treatment and constant supervision, often in intensive care, is referred to as critical illness. Because of the increase in the number of  critical illness cases , such as cancer, stroke, heart attack, and renal failure, the global critical illness insurance market is expected to expand profitably. One of the major factors driving business growth is the growing geriatric population. Since the geriatric population is an unproductive segment of the population, they are unable to afford costly surgical operations or lengthy hospital stays. As a result, having a variety of insurance policies available has a positive effect on business development. However, during the forecast era, a lack of knowledge about cri

 In recent years, the pharmaceutical industry has seen a high degree of automation, which has affected many aspects of the industry due to the significant benefits it brings to consumers. Several government authorities in developed and emerging regions have emphasized the high efficacy rate of  management systems in pharmacy , resulting in market development. Furthermore, the prevalence of chronic diseases is rising, necessitating the implementation of effective pharmacy management systems in developing and underdeveloped countries. Pharmacy Management System Market  held a value of USD 37.23 billion in 2018, at a CAGR of 11.55% during the review period. Compound features such as vendor lock-in, on the other hand, create a dependency for pharmacists, making the onboarding of a new vendor more difficult, potentially limiting pharmacists' preference for such solutions. This will limit the market's growth during the forecast period. Some of the Key Players in the Global  Pharmacy

 The global HbA1c testing market is likely to touch USD 1,992.44 million at a 12.24% CAGR between forecast period, as per Market Research Future's (MRFR) new report. HbA1c or  hemoglobin A1c test  is a blood test used to diagnose and monitor type 1 type 2 diabetes. This is a protein that links with sugars like glucose that is found in red blood cells. Patients having diabetes have a high level of HbA1c in their body as this form during the process called glycosylation that includes glucose conversion into glycogen, especially for storage purposes.  Various factors are adding to the global  HbA1c Testing Machine Market . Such factors, according to the new MRFR report, include investment in RD for novel drugs, improved drug delivery, sedentary lifestyle, obesity, and improper diet. Besides, increasing geriatric population, rising prevalence of diabetes, increased scope of medical tourism, growing awareness to manage diabetes, proliferated diagnostic laboratories, especially in remote

 The bronchodilators market is rising pervasively, mainly due to increasing technological improvements in bronchodilators over the recent past. Bronchodilators are used rigorously for all respiratory disorders. Hence, a rise in the prevalence of COPD, pulmonary disorders, and asthma drives market growth predominantly. Moreover, growing government initiatives for creating awareness among the population escalate the market to furthered height. Bronchodilators companies  are investing substantially to drive RD activities and clinical trials, which, in turn, impact the market growth positively. Growing funding support by government organizations, alongside the rise in disposable income, foster the growth of the market excellently. According to Market Research Future (MRFR), the global bronchodilators market is projected to reach a valuation of USD 2,484 MN, registering 5.3% CAGR during the review period. Conversely, the side effects associated with  bronchodilators market  are estimated to

 Various factors are adding to the global anxiety disorder treatment market share. These factors, as per the new MRFR report, include the launch of technologically advanced therapies, change in lifestyle, increasing geriatric population having anxiety disorders, availability of favorable reimbursement policies especially in developed countries for therapies medication, need for effective  symptoms of anxiety , and rising prevalence of anxiety disorders such as agoraphobia, generalized anxiety disorder, social anxiety disorder, and others. Additional factors adding market growth include high success rates, burgeoning demand for antidepressants for minimum side effects, and increasing consumers’ awareness about various anxiety disorder treatments. The global  anxiety disorder treatment market  was valued USD 11.54 million in 2018 and is predicted to grow at a 5.4% CAGR between forecast period, reveals the new Market Research Future (MRFR) report. Anxiety disorder, simply put, is a mental

Market Research Future (MRFR) studied the global pharmacovigilance market for the assessment period. MRFR assessment study reveals that the global pharmacovigilance market is anticipated to register 14.1% CAGR and earn value USD 4321.86 Mn. Pharmacovigilance service providers  are supporting the safe and appropriate use of drugs and contribute to the identification of risk factors involved in the development and administration of adverse drug reactions (ADR). The need to for detecting unknown ADR is expected to support the growth of the pharmacovigilance market in the near future.  The expansion of the  pharmacovigilance market  can also be attributed to the presence of well-established players involved in the design, development, and launching of products with strategic collaborations to strengthen their global presence. For instance, Accenture, an Ireland-based MNC service provider and consulting company, launched INTENT to enhance the continuity and flow of data across different lif

 The global  pseudomonas aeruginosa treatment market  is expected to cross USD 7.5 billion by 2025. It can achieve growth at  r a CAGR of 7% over the forecast peiod. It stood at USD 1 billion in 2018. Development of suitable vaccines for fighting non-communicable and hereditary diseases is likely to drive the market demand. For instance, antibody tests for testing the strength of pseudomonas aeruginosa in cystic fibrosis can used to determine the strength of vaccines.  Huge prevalence of bacterial infections and its causal mortality rate can drive the demand for antibiotic drugs. For instance, the World Health Organization (WHO) has developed a top priority pathogen list which includes the soil bacteria. Focus of pharmaceutical companies in the development of drugs for  treatment of pseudomonas aeruginosa  and approvals by federal agencies of nations can bolster the market demand. Rise of health-acquired infections (HAIs) caused by soil bacteria can drive the demand in the global pseud

 According to Market Research Future (MRFR), the global orthopedic braces market is estimated to cross USD 5.8 Billion at a CAGR of 6.1% from Forecast period. The study provides for a thorough analysis of the effect of COVID-19 on current / future market situations. The study also focuses on key market factors that will impact this sector's growth, such as market share, the top region, and major producers. Orthopedic braces market  are mainly used in injury prevention, injury rehabilitation, post-operative treatment, and osteoarthritis. These are also used to support, protect, and strengthen the joints and muscles and are used by athletes to avoid injury. The increase in the number of orthopedic surgeries is anticipated to fuel the global market's growth for  types of orthopedic braces . In 2017, it was projected that almost 78 million U.S. adults over 18 years of age would be diagnosed with osteoarthritis by 2040. An increased geriatric population is expected to propel the mar

 The global laboratory equipment market size is likely to touch USD 58,960 million at a 7.3% CAGR between the period (forecast period), according to the recent Market Research Future (MRFR) report.  Laboratory equipment  are instruments used by scientists or lab technicians for conducting experiments. These are used in studying biopsies for diagnosis of different diseases, analysis of patients, preparation of cell culture mediums for research, and others. Increasing funds by government organizations for fueling research and development, an increasing number of mergers acquisitions by top industry players, increasing support by private public companies, increasing need for accurate diagnosis, and growing technological advancements. New avenues of biotechnology, agritech, and microbiology are expected to pave the way for the market. Besides, favorable insurance policies for laboratory equipment and an increase in public private healthcare investments are drivers favoring the  laboratory